About CDC’s Progress
Prevention
Surveillance & science:
More effective tracking and prevention of healthcare-associated infections, foodborne illness and gonorrhea (a sexually transmitted infection).
Improved antibiotic & antifungal use:
Improving antibiotic and antifungal use to ensure these drugs are available and work to protect people from life-threatening infections.
Innovation
Insights for practice:
Innovations and collaborations with academic and healthcare partners to identify and implement new ways to prevent antimicrobial-resistant infections and their spread.
Research & development:
Sharing isolates that inform development of new drugs and diagnostics and making CDC's sequencing data from antimicrobial-resistant pathogens public to spur innovation in the industry.
Download now: CDC is Innovating to Fight AR
Download now: CDC is Innovating to Fight AR
Detection, response & containment
Laboratory & diagnostics:
Standardized lab capacity offered to all U.S. state and regional labs through CDC’s AR Laboratory Network.
Epidemiology capacity for response:
Increased capacity in state, territorial and local health departments for rapid detection and faster response to outbreaks and emerging resistance related to healthcare-associated infections, foodborne bacteria and gonorrhea (a sexually transmitted infection)—to contain and control spread.
Highlights since 2016
1 million+ total tests conducted by the AR Lab Network
Whole genome sequencing on more than 515,000 germ samples
AR Lab Network has detected about 47,000 resistant germs that required investigation
Nearly $800 million in annual appropriation distributed to 63 state, territorial, and local health departments
Supporting 500+ local AR experts